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Over the past several decades, atomistic simulations of biomolecules, whether car-
ried out using molecular dynamics or Monte Carlo techniques, have provided detailed
insights into their function. Comparing the results of such simulations for a few closely
related systems has guided our understanding of the mechanisms by which changes
like ligand binding or mutation can alter function. The general problem of detecting
and interpreting such mechanisms from simulations of many related systems, how-
ever, remains a challenge. This problem is addressed here by applying supervised and
unsupervised machine learning techniques to a variety of thermodynamic observables
extracted from molecular dynamics simulations of different systems. As an important
test case, these methods are applied to understanding the evasion by HIV-1 protease
of darunavir, a potent inhibitor to which resistance can develop via the simultaneous
mutation of multiple amino acids. Complex mutational patterns have been observed
among resistant strains, presenting a challenge to developing a mechanistic picture of
resistance in the protease. In order to dissect these patterns and gain mechanistic in-
sight on the role of specific mutations, molecular dynamics simulations were carried out
on a collection of HIV-1 protease variants, chosen to include highly resistant strains and
susceptible controls, in complex with darunavir. Using a machine learning approach
that takes advantage of the hierarchical nature in the relationships among sequence,
structure and function, an integrative analysis of these trajectories reveals key details
of the resistance mechanism, including changes in protein structure, hydrogen bonding
and protein-ligand contacts.
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Organisms use mutation to respond to changes in environment. In so doing, they can produce
novel protein variants whose modified physical characteristics, such as structure or dynamics,
may offer a functional advantage under the selective pressure imposed by the altered environ-
ment. When the environmental alteration is due to the presence of a therapeutic agent, the
variants with an advantage are said to be “resistant”. Some well known examples where the
altered biophysical properties of protein variants are understood to confer resistance include
the T790M mutation in EGFR kinase and mutations at or near the catalytic site of HIV-1
protease. In EGFR kinase, the T790M mutation induces changes in ATP binding, thereby
evading inhibitors used in cancer therapy,1,2 while in HIV-1 protease, resistance can occur
through mutations that cause a loss of favorable interactions at the binding site with its
inhibitors, accompanied by a relatively mild compromise in the binding and processing of
natural substrates.3–6 Despite important examples such as these, however, the general prob-
lem of relating physical changes induced by mutations with functional outcomes remains a
significant challenge.
The inference problem outlined above is inherently hierarchical, with protein function
being dictated by changes at the sequence level, but mediated by alterations in physical
properties. A variety of machine learning techniques naturally lend themselves to decipher-
ing such relationships. In this study, a combination of supervised and unsupervised machine
learning strategies is assessed for this problem via an application to HIV-1 protease evasion
of antiviral inhibition. Specifically, the singular value decomposition (unsupervised) and reg-
ularized regression (supervised) techniques are used to analyze thermodynamic observables,
including mean protein-inhibitor van der Waals energies, mean hydrogen bond occupancies
and protein Cα−Cα distances, collected from atomistic simulations of several susceptible and
resistant protein-ligand systems.
Principal component analysis7 (PCA) and its formulation using the singular value de-
composition8,9 (SVD) represent venerable strategies for dimensionality reduction and pat-
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tern detection. As such, these methods can be described as unsupervised machine learning10
and while these techniques have been used for a long time in many fields, there is a his-
tory of application to atomistic simulations specifically. PCA and SVD analysis methods
(and the closely related quasiharmonic analysis11–13) have been developed for characterizing
protein molecular dynamics (or Monte Carlo11,14) trajectories.15–17 These applications have
been used to identify slow collective variables for chemical insight14–17 and as an ingredient
to model reduced dynamics.18,19 More recently, autoencoders (neural networks) have been
applied to trajectories from molecular simulations as an alternative dimensional reduction
technique to PCA.20–23
Likewise, supervised machine learning techniques, where data labels are used to train
predictions, have been applied to atomistic models and simulations. Some of these appli-
cations include using regularized kernel ridge regression on molecular geometry and charge
descriptors to predict molecular atomization energies24 or on basis functions to construct
density functionals.25,26 Neural networks have been used to define potential energy surfaces
trained on quantum mechanical energies,27,28 to define free energy surfaces,29,30 or for charge
assignment31 for force field parameterization32 and other applications.
For the most part, these applications of machine learning to atomistic simulations have
been directed in an effort to construct efficient and accurate approximations for a many-body
problem,24–28,31–34 or to characterize the reaction coordinates for a given system.14–23,35 In
contrast, the approach presented here uses machine learning to detect an association between
the occurrence of specific physical changes and functional outcomes among a set of systems
that sample different phenotypes. Applied to HIV-1 protease, this problem corresponds to
selecting a subset of chemically intuitive thermodynamic observables (e.g. mean hydrogen
bond occupancy between donor A and acceptor B, etc.) that can be used as “features” to
accurately distinguish between drug susceptible and resistant protease variants among a set
of strains that includes examples of both classes. This problem is similar to scoring protein-
ligand binding affinity from static (e.g. x-ray crystallographic) structures,36–42 except that
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the starting point here is a set of properties extracted from simulated systems at thermal
equilibrium in aqueous solution, as opposed to fixed structures, with a clear emphasis placed
on the interpretability of these features. Moreover, by modeling the dependence of altered
physical properties on protein sequence, the current approach is designed to respect the
hierarchy of mutations, physical properties and protein function described above.
The remainder of the paper is organized as follows. Background on the HIV-1 protease
and its potent inhibitor darunavir43,44 is presented in the following section, along with a
description of the HIV-1 protease variants studied here. The Methods section includes a
description of the simulations that were used and a brief outline of how SVD is applied to
analyze multiple related systems, followed by strategies for combining SVD on simulation-
based estimates of physical properties with regularized regression on protein amino acid
sequence, and for a purely regression-based (supervised) approach. Results are presented for
cross-variant analysis of HIV-1 protease binding to darunavir, characterizing the relationship
between resistance to inhibition and changes in mean protease-inhibitor van der Waals ener-
gies, mean hydrogen bond occupancies and protein Cα−Cα distances, respectively. Finally,
a summary is given of the general utility of the techniques presented here, which can be
applied to a variety of systems, along with the specific insights gained by applying them to
study drug resistance in HIV-1 protease.
Background: HIV-1 protease inhibition and resistance
The human immunodeficiency virus type-1 (HIV-1) is an RNA retrovirus that leads to ac-
quired immunodeficiency syndrome (AIDS) among infected individuals. The HIV-1 genome
encodes the sequences of 19 proteins, including a protease enzyme that is required for the
cleavage of polypeptide precursor molecules into mature proteins. HIV-1 protease is a homo-
dimeric aspartic protease composed of 99 amino-acid monomers, with access to the active
site controlled by a pair of flaps45 (see Fig. S1). Because this protease is essential for the
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production of infectious virions, it was an early and important target for drug therapies to
inhibit its function.46
Darunavir43 is an HIV-1 protease inhibitor with high binding affinity44,47 that can be
effective against strains where resistance to other inhibitors has developed.43,44,47,48 Despite
this effectiveness and the associated delay in the onset of protease resistance to darunavir
inhibition, however, resistance has been observed in the presence of multiple simultaneous
mutations.49,50 As with some other inhibitors,51 many of these mutations are distal from
the catalytic site,49 making their effects on inhibitor binding more difficult to interpret than
those of proximal mutations, where the substrate envelope hypothesis, which predicts that
HIV-1 protease inhibitors that fit within the overlapping consensus volume of the substrates
are less likely to be susceptible to drug-resistant mutations,4 is a useful guide. In order
to gain mechanistic insight into the role that specific mutations play in this resistance,
molecular dynamics simulations were previously carried out on 15 selected HIV-1 protease
variants,52 chosen to include drug susceptible wild-type controls, along with strains that are
resistant to darunavir in vivo50 and/or in vitro.52 Here, we focus on using supervised machine
learning to analyze thermodynamic observables, such as mean intra-protease hydrogen bond
occupancies, collected from this set of simulations.
The sequence variants of HIV-1 protease that were selected for study with molecular
dynamics simulations are listed in Table 1 and comprise enzymes that were determined, by
various means, to be susceptible or resistant to darunavir inhibition. Shorthand names for
each variant (e.g. “VSL”, “VEG” etc. for variants with multiple mutations and descriptive
names such as “V32I” for variants with a single mutation) are used throughout and are
listed in Table 1. The amino acid sequence for each simulated protease variant, including
two well-studied wild-type enzymes, the NL4-3 clone54 and the Q7K autolysis resistant vari-
ant55,56 of the ARV2/SF2 strain,57 here simply called “SF-2”, are listed in the accompanying
multiple sequence alignment (Fig. S2). This panel of 15 HIV-1 protease variants includes
several well known mutations, such as L10F, V11I, V32I, L33F, K43T, M46I, I47V, G48MV,
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Table 1: Darunavir resistance in 15 selected HIV-1 protease variants. Variant names
are colored according to their categorical label in the “susceptible” column. The amino










SF-2 2 1 Yes
NL4-3 0.8 1 3.98 1 Yes
V32I 7 3.5 Yes
L33F Yes c
L76V 3 1.5 Yes
I84V Yes c
I93L Yes c
DM 45 22 No
DRVr8 No c
DRVr10 No c
VSL 31.2 39 320 80 No
SLK 19.2 24 32.5 8 No
KY 89.6 112 1160 291 No
ATA > 200 No
VEG > 200 7800 1959 No
a Reported by Ragland et al.53 b Reported by Varghese et al.50 c Reported by Ragland et al.52
I50V, F53L, I54MSV, Q58E, G73ST, L67V, V82FA, I84V, L89V and L90M, that are asso-
ciated with resistance to inhibition.50,58,59 Individually, none of these mutations is known to
significantly diminish the binding affinity of darunavir for the protease.49 In different com-
binations, however, resistance has been observed50 (see Table 1 and Fig. S2). As some of
the mutations listed above are distal from the active site of the enzyme, understanding how
they affect inhibitor binding is not straightforward. Indeed, while the complex mutational
response that characterizes resistance (to darunavir inhibition) in HIV-1 protease makes un-
covering mechanistic insight such a challenging problem, it also suggests machine learning
as a particularly appropriate strategy to apply.
A variety of measurements to assess inhibitory activity are available, including inhibitory
constants (Ki), the inhibitor concentration yielding 50% inhibition in the concentration-
response curve (IC50), or 50% effective concentrations (EC50) from phenotypic dose-effect
curves. In Table 1, some of the protease variants listed have one or more of these related60
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measurements associated with them, while the susceptibility of other strains to darunavir
inhibition is known only qualitatively from monitoring populations in cell culture exper-
iments:52 resistant stains are abundant under conditions where inhibitor concentration is
high. When confronted with disparate and sometimes qualitative target data such as these,
it is useful to cast the problem as one of classification. Accordingly, each HIV-1 protease
variant listed in Table 1 is assigned a binary classification as either “susceptible” or “not
susceptible” to darunavir inhibition.
Methods
Molecular dynamics simulations of inhibitor-bound HIV-1 protease
variants
Each of the variants listed in Table 1 has previously52 been simulated in complex with
darunavir using molecular dynamics. Where darunavir-bound crystal structures were avail-
able53 (the SF-2, V32I, L76V and DM variants), they were used as starting coordinates,
including crystallographic water molecules, for the simulations prior to structural optimiza-
tion, equilibration and data collection. Otherwise, homology models were used as initial
coordinates.52 The homology models were constructued from x-ray crystal structures to in-
clude darunavir and the important bridge water molecule between the inhibitor and the
protease flaps. Tautomerization states were optimized using Epik61,62 from the Schrödinger
Suite and hydrogen-bond networks and protonation states were determined and optimized
using PROPKA63 at pH 7.0, with exhaustive sampling of water orientations and minimiza-
tion of the hydrogen atom configurations of altered species. The protonation states for the
catalytic aspartic acid residues were asymmetric.53,64 Finally, interaction energies of hydro-
gen atoms were minimized under the OPLS200565 force field.
Simulations were carried out in an orthorhombic unit cell with periodic boundary condi-
tions, explicit TIP3P aqueous solvent66 at physiological (and electrostatically neutral) 150
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nM NaCl concentration. The smooth particle mesh approximation67 to the Ewald sum was
used to evaluate Coulombic interactions. The isothermal-isobaric ensemble was simulated for
a total of 300 ns (in three separate 100 ns simulations with randomly initialized velocities) at
300 K and 1 bar using the Desmond68 implementation of the Martyna-Tobias-Klein extended
system.69 The OPLS200565 force field was used with multiple time steps70 employed in the
integrator for short-range (2 fs) and long-ranged (6 fs) interactions and a 9 Å cutoff applied
for non-bonded interactions. Fast vibrational motions were constrained using the SHAKE71
algorithm. In aggregate, 4.5 µs of simulations were collected.
Although simulations were carried out for both susceptible and resistant variants of HIV-
1 protease in complex with darunavir, the inhibitor did not escape from the active site in
any of the simulations. Examination of the root-mean-square displacement (RMSD) for
the protease Cα atoms during these simulations reveals that the sampled conformations
were within an RMSD of less than about 2 Å of the initial structures (Fig. S3). These
conformations correspond to well-sampled bound states with no flap opening. Examination
of the per-residue root-mean-square fluctuations (Fig. S4), however, indicates that increased
fluctuations at the flap, flap elbow and cantilever are prevalent among the resistant variants.
In order to understand how various microscopic interactions observed in these simulations
can be used to classify sequence variants as either susceptible or resistant, thereby gaining
mechanistic insight into how the enzyme evades inhibition, thermodynamic averages for
ligand-protease van der Waals interactions, intra-protease hydrogen bond occupancies and
intra-protease Cα−Cα distances collected from these simulations were analyzed here using
unsupervised and supervised machine learning.
Unsupervised learning on trajectories from multiple systems
The singular value decomposition is used in a wide range of applications that encompasses
pseudoinverse and optimization problems,9 and signal processing, including dimensionality
reduction. The familiar decomposition theorem is easily stated: for a n× p data matrix D,
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the singular value decomposition is
D = UΣVT ,
where the non-zero elements of the diagonal matrix Σ are the singular values, U is a n× n
unitary matrix in the column space of D and V is a p× p unitary matrix in the row space







If the matrix D is centered, the singular value decomposition can be used to compute the
principal components for a covariance matrix of the data. There are different choices for















where D′ is the raw data matrix. When the row mean (eq. 3) is used, DDT becomes
the covariance matrix of the rows, by substitution into eq. 1. The corresponding principal
components are the left singular vectors, ui, which are conventionally ordered by the singular
values si along the diagonal of Σ. The variances of the principal components are proportional
to s2i (eq. 1). Alternatively, subtracting the column mean (eq. 4) makes DTD the correlation
matrix of the columns.
Here, the interest is in applying the SVD to sets of p thermodynamic observables collected
from atomistic simulations of n systems. The corresponding matrices of thermodynamic
observables that are considered include mean per-residue ligand-protease van der Waals
interactions, DLJ (computed using the Lennard-Jones potential from the OPLS200565 force
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field), intra-protease hydrogen bond occupancies, DHB, and intra-protease Cα−Cα distances,
DdCα . In the case of the mean van der Waals energies, for example, there were p = 64 residues
that had non-zero mean interaction energies with the ligand in at least one of the simulated
systems. Following the machine learning nomenclature, these p observables can be called
“features”. Column centering (eq. 4) is used in conjunction with SVD to determine the
“eigenfeatures”, which are the right singular vectors, vi. The first eigenfeature, v1, defines
the axis of highest variance in the space of the features, while the corresponding principal
component score s1u1 gives the coordinates for the n systems in the principal component
space. Together, the right and left singular vectors can provide valuable insight into which
features are most responsible for phenotypic changes. For example, if s1u1 (or, equivalently,
the unscaled left singular vector u1) effectively delineates the HIV-1 protease strains that
are susceptible and resistant to its inhibitor, then projecting the eigenfeature v1 onto the
original features can identify particularly important (i.e. large) components.
The ability to read mechanistic meaning from the easily interpreted components of a
given vk (e.g. van der Waals or hydrogen bonding interactions between specific pairs of
atoms) may come at the expense of not finding the most compact low-dimensional represen-
tation of the data matrix (e.g DLJ). By using SVD to carry out dimensional reduction, one
is restricted to a linear transformation of the input data, yet it might be possible to find a
lower-dimensional embedding that separates the susceptible and resistant strains via a non-
linear transformation such as an autoencoder. Although it has recently been informative
to relate the distributions of latent variables for an autoencoder representation of various
systems to physically interpretable collective variables for phase transitions75 and reaction
coordinates,76 choosing to employ SVD for the current application can nevertheless be mo-
tivated by the convenience of interpreting the individual components for a vk of interest
versus the weights of a neural network.77
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Penalized regression for principal components
The unsupervised analysis outlined above, on p features extracted from simulations of n
systems, addresses only half of the problem that was laid out in the Introduction: varying
physical features can now be associated with a change in phenotype, but no information
regarding how sequence (i.e. a set of specific mutations) underlies these changes is provided.
This connection connection can be made by applying a supervised learning approach. For
example, a linear model may be fitted to the component scores siui. Linear models, as
opposed to more general supervised approaches like support vector machine,78 support vector
regression,79 random forest80 etc., can have the advantage of easier interpretability.
The principal components are interpreted most readily when the spectrum of the singular
values is sharply peaked—in other words, low in entropy81—and when phenotypic variation
correlates with variation in one of the leading component scores. Without loss of generality,
one can assume that at least one of the component scores, s1u1 for example, can be used to
delineate different phenotype classes. In this case, a relationship between this variance and
sequence changes among the n simulated protein variants can be formulated using a linear
model. After first defining, u1 ≡ u, the (unscaled) score for each protein variant 1 ≤ i ≤ n
can be written:
ui = β0 + x
T
i β + εi = β0 +
m∑
j=1
xijβj + εi, (5)
where β0,β are the coefficients, εi is the random error associated with protein variant i and
xij is the jth covariate of variant i, defined here as an indicator variable for amino acid
substitutions at candidate site j:
xij =
 0 for wild-type amino acid at candidate site j of variant i1 for non-wild-type amino acid at candidate site j of variant i.
For the set of HIV-1 protease variants studied here (Table 1), there are m = 50 (1 ≤ j ≤ m)
sites that vary out of the 99 total residues present (see Fig. S2). The n × m covariate
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matrix X for the panel of n = 15 protease variants is represented in eq. S1 (Supporting
Information). Note that since the wild-type NL4-3 reference strain is included in X, with
xTNL4−3 the null vector, then uNL4−3 = β0 is the intercept.
The coefficients in eq. 5 can be fitted by regression. In the protease panel (Table S1),
however, the number of predictors (i.e. amino acid positions with sequence variation) is
greater than the number of observations (i.e. sequence variants), so regularization82,83 is




















β2j + α|βj| (6)
is the elastic-net penalty.83,85 In fitting the coefficients β0,β, the elastic net parameter (α ∈
[0, 1]) was α = 0.95 and γ was chosen to minimize errors under five-fold cross-validation, with
larger values of γ implying a larger penalty and a sparser (i.e. with a smaller number of non-
zero coefficients), more interpretable, but perhaps less accurate solution. The relatively high
value chosen for the elastic net parameter means that the l1-norm penalty (i.e. the
∑
j α|βj|
term in eq. 6) is emphasized. Because the l1-norm penalty leads to sparser solutions,82 this
emphasis serves to develop insight by selecting only the most important sites of amino acid
variation for predicting u. The elastic net penalty includes an l2-norm penalty, the presence
of which has been shown to aid in feature selection when correlation among features is
present,83,84 as is the case for the problems described here. Taken its own (i.e. when α = 0),
the l2-norm penalty leads to ridge regression.86
In regression problems with correlated predictors, both the l1-norm and l2-norm penalty
in eq. 6 can improve parameter estimation by shrinking the coefficients. Whereas correlated
predictors will are retained under the l2-norm penalty, the behavior under the l1-norm penalty
is different and the coefficients of some correlated predictors will be set to zero, thereby
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selecting a subset of features that capture the strongest effects.82,83 As a feature selection
procedure for high dimensional regression problems, applying the elastic net penalty has
the desirable characteristic of being a convex optimization problem, allowing for numerically
efficient solutions. The feature selection associated with applying the l1-norm penalty is
desirable here precisely because it aids in the identification and interpretation of important
mutations in eq. 5. One caveat, however, is that one might be interested in identifying
highly correlated (or even collinear) features.
Finally, the estimates for non-zero coefficients derived from applying the l1-norm penalty
are known to be biased toward zero. As the principal motivation for using this penalty here is
to help identify important features—in eq. 5, these features are mutations—any such bias is
not generally of concern. When making predictions using the model, however, removing this
bias can offer an improvement. A two-stage process, whereby features were selected using
the elastic net penalty and another regression model was subsequently fitted by applying
ordinary least squares to the selected features, called the “relaxed lasso”,87 or in the present
case “relaxed elastic net”, has been used here wherever coefficients have been reported.
Sequential penalized regressions
As an alternative to the partially unsupervised approach described above, supervised learning
can be performed directly on p properties extracted from simulations of n systems. Such an
approach can be an advantage in cases where no single principal component score, siui, is able
to adequately discriminate changes in phenotype among the different systems. Even in cases
where one of the principal component scores effectively partitions different systems according
to phenotype, however, interpreting the variances captured by different features may not be
straightforward, as only a subset of the projections for the corresponding eigenfeature, vi,
may vary according to phenotype. In such cases, the simplified feature selection permitted
by beginning from a supervised learning approach, where the most phenotypically important
features are identified without the need for an element-wise examination of eigenfeatures,
14
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As noted above, the partial and heterogeneous nature of the target data for these n
systems (see Table 1) makes it appropriate to cast supervised learning on p features as a
classification problem. A binary (e.g. susceptible versus resistant) classifier can be written




= β0 + D
T
i β + εi = β0 +
p∑
j=1
Dijβj + εi, (7)
where Yi ∈ {0, 1} is the binary response (i.e. taken from the “susceptible” column in Table 1)
for system i and Pr(Yi = 1|Di) is the conditional probability of observing a positive response,
given the covariate vector Di. The term on the left hand side of eq. 7 is the log-likelihood
ratio, β0,β are the coefficients, εi is the (logistic distributed) random error associated with
system i (1 ≤ i ≤ n) and Dij is the jth covariate of variant i. This model makes an obvious
analogy with that in eq. 5, but the matrix of covariates in eq. 7 is now just the data matrix
D. In data-sets that are large enough to support multi-category responses, eq. 7 can be
generalized to multinomial logistic regression83 and in data-sets where the response variable
is known quantitatively for each case (e.g. an inhibition constant has been measured for all
variants in Table 1), the problem could be formulated as a multiple linear regression.
The coefficients in eq. 7 may be fitted by maximizing the likelihood (or equivalently,











where Pα(β) is the elastic net penalty (eq. 6), L is the log-likelihood for the logistic function
and Y = {Y1, Y2, ..., Yn}. As above, regularization using an elastic net penalty was employed
to limit overfitting and to facilitate feature selection. The elastic net parameter was α = 0.95
and γ was chosen to minimize errors under three-fold cross-validation.
The procedure described above identifies a subset of the physical descriptors that, for a
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given data matrix D, can be used to predict phenotype classes. In the current application,
for example, these descriptors can include van der Waals interactions between an inhibitor
of HIV-1 protease and specific residues in the enzyme; the classes are strains that are “sus-
ceptible” versus “resistant” to darunavir inhibition. The subset of mutations that appears to
control changes in these selected physical descriptors, or features, can be inferred by again
appealing to regression on sequence descriptors, as in eq. 5. Unlike in eq. 5, however, the
outcome variable is now the physical descriptor itself, rather than a principal component
score. For a selected feature, k, one can take D = Dk as the kth column of the data matrix
and fit the following linear model:
Dk = β0 + x
T
kβ + εk = β0 +
m∑
j=1
xkjβj + εk, (9)
where there are 1 ≤ k ≤ n systems and the covariate matrix X is given as in eq. S1.
In this fully supervised approach to analyzing thermodynamic observables collected from
simulations of many related systems, phenotypically important features are identified using
logistic regression (eq. 7) and changes in amino acid sequence are regressed on each selected
feature (eq. 9) separately.
Results
Short-range protein-ligand interactions
As they are sensitive to changes in binding geometry, protein-ligand van der Waals inter-
actions are important probes of affinity38,39 and have been observed to change in response
to resistance-associated mutations in HIV-1 protease.3,52,53,88,89 Furthermore, although en-
thalpic terms other than van der Waals interactions also contribute to the free energy for
ligand binding, changes in van der Waals interactions have proven to be among the most
predictive physics-based features in machine learning estimates of binding affinity in HIV-1
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Figure 1: HIV-1 protease variants projected on top two principal component scores for the
column centered mean per-residue protein-ligand van der Waals interactions.
protease.38
Within the simulations of 15 HIV-1 protease variants studied here, there were 64 residues
that had non-zero mean van der Waals interactions with the ligand over the course of the
simulations. Applying SVD to the column centered 15 × 64 matrix of these data, DLJ,
results in a sharply peaked spectrum of singular values (Fig. S5 (a)) with more than 41% of
the variance accounted for by the first singular value and an additional 21% by the second
singular value. Plotting the unscaled principal component scores, u1 and u2, against one
another for these two singular values shows that the two wild type strains, NL4-3 and SF-2,
are approximately co-localized, as expected (Fig. 1). There is also a significant segregation
of susceptible and resistant strains along u1, with resistant protease variants placed at higher
values (p < 0.04, Fig. S6 (a)). The correspondence between resistance to darunavir inhibition
and u1 is not perfect, however, with two resistant strains, KY and SLK placed at lower scores
among the susceptible strains (Fig. 1).
By examining the corresponding right singular vector, v1, one can assess the relative
importance of different eigenfeature components (Fig. 2(a) and Fig. S7). Many of the mean
van der Waals interactions between darunavir and specific protease residues are ubiquitously
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Figure 2: The resistance-associated signature of changes in ligand-protein van der Waals
interactions is mapped onto the darunavir-bound structure47 of HIV-1 protease. In (a),
residues colored in darker blue indicate a greater loss in van der Waals interactions among
resistant strains, as indexed by v1, while those colored in darker red indicate a greater gain.
Residues colored in white showed no change. In (b), the fitted coefficients from penalized
regression on u1 (eq. 5), defining a predictive subset of mutations, are colored darker violet
for larger values of β. All indicated coefficients are positive, meaning that amino acid
substitutions at those residues imply an increase along u1. Here and elsewhere, the two
monomeric subunits of the HIV-1 protease are labeled “chain A” and “chain B”, with chain
B located proximal to the sulfonamide moiety of darunavir.
weak among the simulated systems and therefore account for very little of the captured
variance. Other interactions, by contrast, are important components of v1 that correspond
to a loss in mean ligand-protein van der Waals energy among the resistant strains at that
residue or to a gain. On balance, v1 catalogs a loss in van der Waals interaction energy
corresponding to the development of resistance, yet there are some residues like V32 in both
monomeric subunits and V82 located in the chain proximal to the sulfonamide moiety of
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darunavir, where the opposite effect is observed (Fig. 2(a) and Fig. S7(b)) among the
strains listed in Table 1. Some of the protease residues with the most altered mean ligand-
protein van der Waals interactions across these variants are located in the flaps, above the
catalytic site as shown in Fig. 2(a). These flap residues include I47, G48, G49 and I50.
Isoleucine 84 is another active-site residue where van der Waals interactions with darunavir
become less favorable in the resistant strains.
As noted above, u1 has a significant, but not perfect, correspondence with resistance
among the HIV-1 protease variants listed in Table 1. Accordingly, one may find residues like
G27, where the van der Waals interactions with the ligand are highly variable among our
panel of protease variants and that have, therefore, large projections onto v1. The mean van
der Waals interactions between darunavir and G27 vary significantly, yet they do so at least
as much within the susceptible and resistant variants as between these two respective classes
(Fig. S7(b)), suggesting that alterations in this interaction do not correlate with darunavir
resistance. This example serves to emphasize that some of the features identified using SVD
may appear important without really delineating the susceptible and resistant variants. For
that task, supervised learning approaches can offer a direct solution.
Having made a connection between one of the principal components of the column cen-
tered matrix of ligand-protein van der Waals interactions and resistance to darunavir inhi-
bition among a set of HIV-1 protease variants, it is natural to ask which specific mutations
can best explain, or predict, changes in this eigenfeature. Carrying out penalized regression
of u1 against the sequence predictors (eq. 5) identifies a subset of residues where mutations
are predictive under cross-validation (Pearson’s r = 0.73, mean square error=0.07, see Fig.
S8(a)). The selected sites of mutation that predict u1 under this model, ordered by decreas-
ing βj are: L19, I84, R57, V32 and M46 (Fig. 2(b), Table S1). All of these coefficients are
positive, meaning that mutations at any of these sites lead to increased u1. Some of these
sites of mutation, like L19 and R57, are not generally associated with resistance to darunavir
or to other protease inhibitors,49,50,58,59 but their importance in the linear model for u1 is
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nevertheless straightforward to understand: the L19Q mutation is present only in the ATA
strain, which has a particularly large score, while R57K is present in the highly resistant
VSL, ATA and VEG strains (see Fig. S2).
As a complementary approach, supervised machine learning on molecular properties col-
lected from simulations of different systems (see Methods) can directly identify resistance-
associated differences that may be masked by other sources of variance (e.g. tolerated vari-
ation among wild-type proteins). Carrying out penalized logistic regression on DLJ (eq. 8),
results in the selection of several features that were also among the important components
of v1 (see Fig. 2 and Fig. S7) from the SVD: the mean ligand-protease van der Waals
interactions at residues G49 and I50 on chain A and at residues I47, A28 and D29 on chain
B. Violin plots for these features are shown in Fig. 3(a), indicating that favorable van der
Waals interactions are lost in the resistant variants (light blue violins) versus the susceptible
variants (dark blue violins) for residues G49, I50 (chain A) and I47 (chain B), while these
interactions can increase for residues A28 and D29 (chain B).
The logistic regression coefficients for the model are represented in Fig. 3(b) as directed
edges that connect each physical feature (blue circles) according to its contribution to the
classification of variants as susceptible or resistant (an outcome that is depicted with a red
circle). The size and shade of these edges is determined by the coefficients of the model (eq.
8) in the following way: recalling that the encoding for variant i is Yi = 0 for “susceptible”
(see Table 1), the odds ratio for coefficient βj is eβ0+βj/eβ0 = eβj and sets the width of
the edges. When the odds ratio is greater than 1 (black edges), resistance is more likely
to occur as the predictor increases, while when the odds ratio is less than 1 (grey edges),
resistance is less likely to occur as the predictor increases. For example, the increase that is
observed among resistant protease variants for the mean van der Waals energy between the
inhibitor and residue G49 (chain A) in Fig. 3(a) is rendered as a black edge in the graphical
representation (Fig. 3(b)) of the fitted model. By contrast, the corresponding decrease that
is observed in Fig. 3(a) for these interactions with residue A28 on chain B is rendered as
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A G49 B I47 A I50 B A28 B D29
(b)
T12 K14 L19 V32 L33 K45 M46 R57 I64 A71 L76 V82 I84 I93







A G49 A I50 B I47
B A28
B D29
Figure 3: Hierarchy of regularized regression models to help decipher drug resistance mech-
anisms in HIV-1 protease. For each predictor (a) in a logistic regression model of resistance
from mean per-residue ligand-protease van der Waals interactions, a linear model of sequence
predictors has been fitted (b). The violin plots in (a) depict the kernel density of mean per-
residue van der Waals energies for susceptible (left, darker blue) and resistant (right, lighter
blue) protease variants. The directed edges shown in (b) correspond to fitted coefficients
and are colored according to sign (black for positive, grey for negative) and sized according
to importance. In (c) the physical and sequence features are projected onto the structure of
the ligand-bound enzyme.
a grey edge in Fig. 3(b): the van der Waals interactions between the inhibitor and this
residue tend to be more favorable among the resistant variants listed in Table 1, compared
to the susceptible variants. The narrow width of the edge that connects residue A28 with
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resistance status in Fig. 3(b) corresponds to a relatively small coefficient in the model.
As noted above, because a strong l1-norm penalty is used in the fitting (eq. 8), the
presence of correlated features will be attenuated in the final model. This behavior is by
design, as the resulting model is sparse and therefore readily interpretable. Furthermore,
one should not generally expect all of the most important v1 components from the SVD to
appear as features in supervised learning: recall that not all of the variance captured using
SVD is related to differences between susceptible and resistant strains. These considerations
can help explain differences between the eigenfeature v1 (Fig. S7) and the relatively sparse
set of features selected using penalized logistic regression (Fig. 3(a)).
For each of the important protein-inhibitor van der Waals interactions that were identi-
fied using supervised learning, a set of underlying sequence alterations can be inferred. As
before, this inference is done using linear regression (eq. 9), but now separately on each of
the features selected using logistic regression instead of on the relevant principal component
scores (e.g. u1). The coefficients for linear regression of the selected van der Waals inter-
actions against sequence features are visualized in Fig. 3(b) as directed edges that connect
individual mutations (violet circles) with interactions (blue circles). These edges are shaded
according to the sign of the coefficients, with black used for positive and grey used for neg-
ative coefficients. The widths of the edges are scaled by the magnitude of the coefficients,
|βj|.
As one example, consider the mutation at residue 46. In panel of HIV-1 protease variants
studied here, this mutation is always from methionine to isoleucine (see Fig. S2) and is a well
known resistance mutation50,58,59 for protease inhibitors, including darunavir. In Fig. 3(b),
this mutation makes a positive contribution to explaining the changes in mean darunavir-
protease van der Waals interactions at three of the selected residues: G49 and I50 in chain A
and I47 in chain B. The positive sign of these coefficients means that each of these interaction
energies increases (i.e. becomes less favorable) when the M46I mutation is present (see Fig.
S9).
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To further illustrate the interpretation of the regression coefficients for sequence features
in Fig. 3(b), consider mutations at residue 71. Mutations at residue 71, such as A71V, are
generally described as “secondary” HIV-1 resistance mutations in the sense that they offer a
reduction in inhibitor affinity only in the presence of additional mutations. In this context,
the A71V mutation has been shown to alter resistance to different inhibitors, either in the
form of enhancement90 or diminution.91 Among the protease variants studied here, the A71I
and A71V mutations are associated with increased resistance (Fig. S2). This association can
be seen via the grey edges (negative coefficients) in Fig. 3(b). When a mutation is present at
residue 71, the van der Waals interactions between darunavir and residues 28 and 29 in chain
B are reduced (i.e. become more favorable, see Fig. S10). These specific alterations in van
der Waals interactions are, in turn, a distinguishing feature of the resistant and susceptible
strains here.
Finally, consider the set of mutations that can be used to model changes in van der
Waals interactions between darunavir and residue 50, chain A. This residue is located at
the tip of one of the two flaps that control access to the catalytic site (Figs. S1, 2(a) and
3(c)). Although residue 50 is known to harbor so-called primary resistance mutations, such
mutations are not prevalent in among the panel of HIV-1 protease variants studied here,
which contains a single example: the VSL variant has an I50V substitution (Fig. S2).
Instead, the observed loss in van der Waals affinity among the resistant strains appears to
be accounted for by the mutations indicated in Fig. 3(b), each of which is represented as a
black edge (positive coefficient). Several of these mutations, like V32I, M46I and I84V are
primary resistance mutations whose effects include a loss in van der Waals affinity between
darunavir and residue 50 (Fig. S11).
Mapping the selected mutations and alterations in van der Waals interactions onto the
structure of the darunavir-bound HIV-1 protease, it is striking to note how many of the
mutations are distal from the catalytic site. The resistance-associated alterations in the
short-ranged van der Waals interactions are naturally localized near the inhibitor, while the
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distal nature of the selected mutations implies that these changes are mediated by structural
and/or dynamical alterations throughout the protease.
Intra-protein hydrogen bonding
Since the analysis of mean inhibitor-protease van der Waals interactions suggests that losses
in affinity at key residues near the catalytic site are mediated by structural alterations
elsewhere in the enzyme, it is reasonable to next interrogate alterations in intra-protease
hydrogen bonding and protein geometry. Hydrogen bonds are essential determinants of
protein secondary structure,92 so resistance-associated changes in protein structure are likely
to have signature alterations to hydrogen bonding.
Between the backbone intra-protease hydrogen bonds and those formed directly between
darunavir and the protease, there were p = 113 non-zero interactions to consider, resulting
in a 15× 113 matrix, DHB. Applying SVD to this column centered matrix of hydrogen bond
occupancies results in a sharply peaked singular value spectrum (Fig. S5 (b)) with more than
34% of the variance accounted for by the first singular value and an additional 16% by the
second singular value. Plotting the unscaled principal component scores, u1 and u2, against
one another for these two singular values shows that the two wild type strains, NL4-3 and
SF-2, are approximately co-localized (Fig. 4), as they were when applying the same type of
analysis to the van der Waals interactions above. Examining the principal component scores,
only u2 offers a significant (p < 0.04, Fig. S6 (b)) discrimination between the susceptible
and resistant variants.
Note that the singular value decomposition offers no assurance that any singular value,
let alone the largest singular value, will effectively account for phenotypic variance or classifi-
cation. There is evidently some variability in intra-protease hydrogen bonding that does not
affect resistance to inhibition. Nevertheless, inspection of u2 offers valuable insight regarding
how intra-protease hydrogen bonds are perturbed among the darunavir-resistant strains.
By examining the right singular vector that is most relevant to resistance, v2, the impor-
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Figure 4: HIV-1 protease variants projected on top two principal component scores of the
centered mean occupancies for intra-protease backbone hydrogen bonds.
tant components of this eigenfeature can be identified (Figs. 5, S12). Unlike with the van
der Waals interactions between the inhibitor and protease, there is no notable overall loss in
hydrogen bonding among the resistant variants, yet patterns of alterations are evident. Sev-
eral of the important components of v2 are interactions between residues in “60s loop” and
the β-sheet that begins at residue 70 (Fig. S12), sometimes called the “cantilever” (Fig. S1).
The changes in hydrogen bonding occupancy for these residues, however, tend to be modest
when comparing resistant and susceptible variants. Other large magnitude components of
v2 include hydrogen bonding within each of the flap tips and between residues 67 and 12
in both chains. The former hydrogen bond occupancies are modestly increased, while the
latter exhibit a dramatic decrease from the susceptible to the resistant variants. Perhaps not
surprisingly, the hydrogen bond occupancy between the flap two tips (residues 50 and 51 in
chains A and B, respectively) shows a decrease among the resistant variants (Figs. 5, S12).
To identify specific mutations that can explain u2, a regression model was fitted (eq.
5). The sequence features that were selected under cross-validation are highly predictive
(Pearson’s r = 0.97, mean square error=0.06, see Fig. S8(b)) and include mutations to L10
and I50 (Table S1), both of which are known to increase resistance to darunavir inhibition.49
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Figure 5: The resistance-associated eigenfeature of changes in intra-protease hydrogen bond-
ing is mapped onto the darunavir-bound structure47 of HIV-1 protease. Hydrogen bonds are
depicted as cylinders colored in darker blue to indicate a greater gain in occupancy among
resistant strains, as indexed by v2, while those colored in darker red indicate a greater loss.
Hydrogen bonds colored in white showed no change in occupancy (see Fig. S12). The fitted
coefficients from penalized regression on u2 (eq. 5), defining a predictive subset of mutations,
are colored darker violet for larger positive values of β and green for negative values (i.e for
βR41 only, see Table S1).
Among the HIV-1 protease variants listed in Table 1, the I50V mutation is present only in
a single strain, VSL (Fig. S2). Including it in the regression model ensures that the high u2
score for VSL is accurately captured (Fig. 4). Likewise, the mutations at L10 (or collinear
mutations at I54 that are not included in the model) delineate the highly resistant patient-
derived variants in the panel. The remaining coefficients in the model are positive, with the
exception of the negative coefficient for a mutation at residue 41. Mutations at residue 41,
therefore, lead to a decrease in u2. The otherwise polymorphic R41K mutation is mostly
present in the susceptible panel variants, making its contribution to the model clear, as u2
is indeed lower for these variants (Fig. 4).
Carrying out penalized logistic regression directly on the hydrogen bond occupancies
in DHB identifies a sparse subset that can be used to classify HIV-1 protease variants as
susceptible and resistant to darunavir inhibition (Fig. 6). These distinguishing hydrogen
bonds include one formed between residue 67, located in a turn between a pair of β-sheets
(sometimes called the “cantilever” 93 of the protease) and residue 12 in a β-sheet (sometimes
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B 12O-B 67N B 10N-B 8O B 49O-B 52N A 49O-A 52N
(b)
L10 V11 I13 N37 R41 K45 M46 G48 I62 I64 A71 L76 V82 I84 L90 I93








A 52N-A 49O B 52N-B 49O
B 10N-B 8O
Figure 6: Visualization of the regularized regression model hierarchy used to to identify
resistance-associated alterations in intra-protease hydrogen bonding. For each predictor (a)
in a logistic regression model of resistance based upon the mean occupancies of intra-protease
hydrogen bonds, a linear model of sequence predictors has been fitted (b). The violin plots
in (a) depict the kernel density of mean occupancies for susceptible (left, darker blue) and
resistant (right, lighter blue) protease variants. The directed edges shown in (b) correspond
to fitted coefficients and are colored according to sign (black for positive, grey for negative)
and sized according to importance. In (c) the physical and sequence features are projected
onto the structure of the ligand-bound enzyme.
called part of the “fulcrum” 93) in chain B. This hydrogen bond is severely disrupted among
some of the resistant variants (Fig. 6(a)), suggesting a possible alteration in the coupling
between these two domain elements of the enzyme. Another disrupted backbone hydrogen
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bond was selected, connecting two residues, 8 and 10, that are located in a chain B turn near
the core of the protease. This turn sits between the core β-sheet structures of the protein
and those at the terminal dimer interface94 (Fig. 6(c)). As both of these hydrogen bonds
are disrupted in resistant variants, their corresponding coefficients in the model (eq. 8) are
negative (grey edges in Fig. 6(b)). Note that, while these two hydrogen bonds in chain B
were selected via penalized regression, their counterparts in the other monomer were similarly
disrupted among resistant variants (Pearson’s r = 0.75 and 0.74, respectively). Adding such
correlated features to a linear model, however, generally offers little predictive benefit and a
sparse set was selected under the l1-norm bias of the elastic net penalty (eq. 9).
Two weaker features that were selected correspond to increased backbone hydrogen bond
occupancies within each of the flaps (Fig. 6). These hydrogen bond occupancies have positive
coefficients (black edges leading to the “resistant” status in Fig. 6(b)). These features can
be omitted from the model, however, without significant impact on prediction: they are
included in Fig. 6 only to identify the most informative of the remaining features.
The mutations that can predict each of the selected hydrogen bond occupancies were
identified using penalized regression and are listed in Fig. 6(b). The substantial loss of
hydrogen bonding observed among resistant strains between the chain B residues 67 and
12 appears to be controlled by mutations nearby residues: 10, 11, 12 and 93. These muta-
tions are variously present among the highly resistant patient-derived strains that exhibit
the greatest disruption of this hydrogen bond (Table S1). In each case, the model coefficient
is negative (grey edges): the presence of amino acid substitutions here leads to a loss of
hydrogen bonding. Mutations at residues 10 and 11 are known to confer resistance to inhi-
bition,50 including by darunavir,49 while the polymorphic I93L mutation, located within the
α-helix and physically close to residue 67, is considered an accessory mutation for resistance.
Disruptions of the hydrogen bond between chain B residues 8 and 10 can be modeled
using mutations at residues 41, 46, 62 and 71. Recall that the polymorphic R41K mutation
is present mainly in the susceptible variants in this study (Fig. S2), so that its coefficient
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should be positive (black edge): this hydrogen bond occupancy increases among susceptible
variants. Otherwise, however, the coefficients are negative (grey edges), including that for
the A71V or A71I mutation.
Protein structure
Having identified resistance-related alterations among close-range inhibitor-enzyme contacts
and more distal alterations in hydrogen bonding, one can also use the simulations to probe
any corresponding structural changes that may mediate these effects. The distances between
Cα atoms can be used to define protein structures: even a sparse set of Cα distances can be
adequate for structural determination.95
Cataloging the distances between pairs of N = 2 × 99 distinct Cα atoms in the HIV-1
protease dimer, there are p = N(N − 1)/2 = 19, 503 to consider, resulting in a 15× 19, 503
column centered matrix of mean distances, DdCα . Applying SVD to this matrix yields a
sharply peaked singular value spectrum (Fig. S5 (c)) with more than 42% of the variance
accounted for by the first singular value and an additional 18% by the second singular
value. Plotting the unscaled principal component scores, u1 and u2, against one another for
these two singular values shows that the two wild type strains, NL4-3 and SF-2, are once
more approximately co-localized (Fig. 7). Examining the principal component scores, only
u2 offers a significant (p < 0.006, Fig. S6 (c)) discrimination between the susceptible and
resistant variants. Considering the profound importance of hydrogen bonding for determining
protein structure, it is unsurprising to observe that the same principal component score (u2)
in the SVD for DHB and DdCα , respectively, is most related to drug resistance.
Because of the extreme “large p, small n” 10 nature of DdCα , a detailed accounting of
each component of the v2 eigenfeature is not feasible. Nevertheless, examination of v2
reveals a relatively small subset of important components (Fig. 8, Fig. S13(a)). After
mapping the components of v2 onto structural elements of the protease (Fig. 8), the most
striking observation is that the β-sheets of the outer core (sometimes called the “cantilever”,
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Figure 7: HIV-1 protease variants projected on top two principal component scores of the
centered mean Cα−Cα distances.
see Fig. S1) for each monomer are further apart from one another in the resistant versus
the susceptible variants. This observation is also apparent from inspection just the k =
75 components with the largest absolute value, |v2k| (Fig. S13(b)). The inter-monomeric
distances between these β-sheets, as measured using Cα atoms, are typically increased by
about 1.5 among the resistant variants, where much greater variances in these distances are
also observed. Exhibiting similar, but more modest increases among the resistant variants,
are the intra-monomeric distances between this β-sheet and the terminal residues at the
dimer interface.
Specific residues where mutations can predict u2 were identified by fitting a regression
model (eq. 5). The sequence features that were selected under cross-validation are highly
predictive (Pearson’s r = 0.98, mean square error=0.04, see Fig. S8(c)) and include familiar
resistance mutations to residues I50, K43, M46 and V82 along with known accessory mu-
tations at A71 and I93 (Table S1). As was the case when the hydrogen bonding matrix,
DHB, was analyzed using SVD, the importance of the I50V mutation in modeling u2 here
lies in accurately reproducing the high score of the VSL variant (Fig. 7). The I62V mutation
that is included in the model (Table S1) is polymorphic, but is present only among resistant
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Figure 8: Resistance-associated variability in intra-protease Cα−Cα distances reveals domain
changes in geometry. For these data, the second singular value, s2, best separates susceptible
from resistant strains (see Figs. 7, S6(c)), so v2 is plotted in the upper triangle. For




∑nsusc. dCα (k) − 1nres. ∑nres. dCα (k), is shown in the lower triangle. For ease of
visualization together in the same plot, both v2k and δk have been standardized, with red
indicating more positive and blue more negative values, respectively. Secondary structural
elements and annotations are shown in the margins (see also Fig S1). There is a notable
positive v2k for the “cantilever” β-sheets between residues 59 and 75, corresponding to a more
open protease structure (i.e. negative δk in the lower triangle) among the resistant variants.
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protease variants studied here (Fig. S2). With one exception, the model coefficients are all
positive, meaning that the predicted u2 increases under amino acid substitution. The single
exception with a negative coefficient is the polymorphic K14R mutation that is prevalent
among the susceptible variants.
As an alternative to the SVD-based approach above, directly selecting alterations of
average distances between specific pairs of Cα atoms using penalized logistic regression iden-
tifies a sparse set of predictive distances. A compact set of four features is presented in
Fig. 9(b), indicating a resistance-associated opening between the monomeric subunits and
a corresponding compression of some structural elements within each monomer (Fig. 9(c)).
Although the features selected under the elastic net penalty are sparse, it is clear from unsu-
pervised learning that the structural alterations that they capture are concerted and involve
each of the 70s β-sheets (i.e. cantilevers) as a whole (Figs. 8 and S13(b)). Apart from using
SVD, an alternative way to detect the concerted nature of these alterations is to reduce
the parameter, α, used in the elastic net penalty (eq. 6), thereby emphasizing the l2-norm
penalty (data not shown).
The mutations that were found to predict each of the selected distances between Cα
atoms are indicated in Fig. 9(b). Among the list of these predictive mutations, most are
familiar from analyzing the hydrogen bond occupancies, such as those at residues 10, 13,
46, 62, 71, 76, 82, 84 and 90. Residues 10 and 13 from this list flank residue 12 and were
also implicated above in the resistance-associated disruption of the hydrogen bond formed
between residues 12 and 67. Consistent with that observation, this same pair of mutations
is found to predict an expansion between the two monomeric subunits of the enzyme (Figs.
9(b) and 9(c)).
With two exceptions, all of the mutations that were selected via separate regressions on
each of the distance features in Fig. 9(a) correspond to concerted expansions and compres-
sions of structural elements that were also characterized using SVD on DdCα . That is, these
resistance-associated structural changes occur when wild-type amino acids are substituted
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Figure 9: Visualization of the regularized regression model hierarchy used to to identify
resistance-associated alterations in HIV-1 protease structure. For each predictor (a) in a
logistic regression model of resistance based upon the mean distances between Cα atoms, a
linear model of sequence predictors has been fitted (b). The violin plots in (a) depict the
kernel density of mean occupancies for susceptible (left, darker blue) and resistant (right,
lighter blue) protease variants. The directed edges shown in (b) correspond to fitted coef-
ficients and are colored according to sign (black for positive, grey for negative) and sized
according to importance. In (c) the physical and sequence features are projected onto the
structure of the ligand-bound enzyme.
at the residues shown in Figs. 9(b) and 9(c). The exceptions to this trend occur at residues
41 and 76, where mutations are associated with the opposite structural alterations. The
case of the polymorphic R41K mutation is straightforward to interpret and by now familiar
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from the preceding analysis: it is mainly present among the susceptible strains. The case
of the L76V mutation, however, is more interesting. In combination with other mutations,
the L76V substitution confers resistance to darunavir50,96–98 but hypersusceptibility to some
other protease inhibitors.96–98 Compensatory mutations are reported to include M46I, I54V,
V82A, I84V and L90M.97 Among the protease variants studied here (Fig. S2), L76V is
present in only the DRVr10 (resistant) and L76V (susceptible) variants. In each class of
variants, susceptible and resistant, the strain with L76V present exhibits the largest dis-
tance between Cα atoms on residues 16 and 62 on chain A, perhaps because the smaller
valine residue allows room for a less compressed contact.
The concerted structural alterations that delineate the susceptible and resistant variants
in Table 1 are consistent with those anticipated from a previous examination of x-ray crys-
tallographic structures of inhibitor- and product peptide-bound HIV-1 and SIV protease.94
Based on this structural comparison, it was suggested that “domain orientation or movement
may be a factor in the development of resistance” due to mutations that are distal from the
active site of the HIV-1 protease but located at the interfaces of its structural domains.94
Among the 15 protease variants studied here, such mutations include those at residues 10,
71, 89, 90 (Figs. S1, S2), physically located near the terminal dimer interface and at residues
20, 32, 33, 35, 45, 54, 63 and 77 (Figs. S1, S2). While some of these mutations are collinear
with other mutations in the panel and therefore do not appear among the selected sequence
features in Fig. 9(c), many of these “interfacial” mutations are present.
Discussion
Overall, applying SVD and regularized regression to data collected from atomistic simula-
tions of many different HIV-1 protease sequence variants has provided useful insights into
how physical alterations in the darunavir-protease complex control binding and lead to resis-
tance. Moreover, relationships between resistance-related alterations in physical properties
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and specific mutations were identified.
It has been a longstanding problem to characterize the mechanisms by which mutations
throughout the HIV-1 protease lead to resistance, particularly for mutations that are located
far from the active site of the enzyme. Using a combination of supervised and unsupervised
machine learning techniques here has revealed that several such distal mutations, including
the known resistance mutations at residues 10 and 11, appear to function by interfering with
important hydrogen bonds within the enzyme, thereby causing broad structural changes
that affect the short-range contacts with the inhibitor. Mutations elsewhere in the protease,
like those at residue 46 in the flaps and residue 71 in the cantilever also contribute to these
alterations, as do mutations that are more proximal to the active site, such as the primary
resistance mutations at residues 32, 82 and 84.
These findings provide detailed support for the idea that alterations to the network of
intra-protease hydrogen bonds are an important signature of drug resistance in HIV-1 pro-
tease.52,53 Because much of the variability in this network among our panel appeared to be
unrelated to drug resistance, however, the techniques presented here were particularly impor-
tant for detecting such signatures. In other words, this analysis has emphasized the utility
of filtering the noise in these data by applying either SVD or direct penalized regression.
Given a matrix of p thermodynamic observables extracted from n simulations, SVD of-
fers a convenient route to dimensionality reduction, which can offer insight into how the
observables (e.g. mean van der Waals interactions or hydrogen bonds etc.) relate to ex-
perimentally measured properties (e.g. resistance to inhibition) of the simulated systems.
Examining the components of key singular vectors can characterize the relative importance
of the p observables. Ideally, SVD can identify a coordinate that explains all differences
among the measured properties. There is no assurance that this will be true, however, in
which case supervised machine learning can provide additional insight.
Penalized regression was used here to sequentially apply supervised learning to simulation
and sequence data, with the objective of extracting a compact set of readily interpretable
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mutations and altered thermodynamic observables. To this end, the elastic net penalty was
applied with the goal of finding the sparse solutions implied by emphasizing its l1-norm
penalty. Compared with SVD or other unsupervised learning techniques, this supervised
approach has the advantage that the features selected by the procedure are, by design, able
to distinguish the different phenotype classes. For example, the five inhibitor-protease van
der Waals interactions that were selected can be used to accurately distinguish between
HIV-1 protease variants that are susceptible and resistant to darunavir inhibition. If a
broader set of features is desirable, to detect alterations throughout an element of protein
secondary structure, for instance, the elastic net penalty can be parameterized to place a
greater emphasis on its l2-norm penalty.
While the results here demonstrate that changes among select thermodynamic observ-
ables collected in the bound ligand-inhibitor complex can predict resistance status and can
be leveraged for useful insights into the resistance mechanism, the unbound states of the
system(s) have not been explicitly examined. These unbound states are characterized by
a separate protein and ligand, each in aqueous solution. For the present study, darunavir
is common to all systems, so its properties in bulk solution cannot inform differences in
resistance among the HIV-1 protease variants. It is possible, however, that unbound states
of the protease variants affect resistance by, for example, altering the cross section for the
ligand to encounter the active site.99,100 A straightforward extension of the present methods
would be to simulate such states and include their features among the predictors.
The methods presented here could also be readily extended to include finer details of the
short-range inhibitor-protein interactions. This extension could be accomplished, for exam-
ple, by separately considering m different molecular fragments, or moieties of the inhibitor.
The data matrix DLJ would then include a longer list of p′ = m · p predictors. Bearing in
mind the limitations implied by the size of n relative to that of p′, analyzing this n × p′
matrix can offer more detailed insights into the development of resistance, thereby informing
the design of improved inhibitors.
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Overall, applying SVD and regularized regression to data collected from atomistic simula-
tions of many different HIV-1 protease sequence variants has provided useful insights into
how physical alterations in the darunavir-protease complex control binding and lead to resis-
tance. Relationships between resistance-related alterations in physical properties and specific
mutations were identified.
The methods presented here have been applied to study drug resistance in HIV-1 protease,
yet these techniques are broadly applicable to data from a variety of atomistic simulations.
For example, given structural information and measurements of binding affinity for a se-
ries of antibodies and a target protein (or possibly multiple targets), important interaction
sites could be identified for refinement. Likewise, given structural and binding information,
simulations for a series of protein-RNA/DNA complexes could be used to characterize the
molecular details of specificity and carry out refinement.
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